Skip Navigation Links.

Glenmark Pharmaceuticals Ltd


BSE: 532296 | NSE: GLENMARK | ISIN: INE935A01035 
Market Cap: [Rs.Cr.] 15,472 | Face Value: [Rs.] 1
Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

 Discuss this stock
567.05-4.10 [0.7]%
571.450.00 (0.0%)
BSE Jun 20,09:08
Day's High | Low 0.00 | 0.00
Day's Volumes 0
52Wk High | Low 609.70 | 0.00
Open Price 0.00
Turnover 35,754,070.00
Deliverable Vol. 11,704
6 Mth. Avg. Vol. 210,155.65
NSE Jun 19,00:00
Day's High | Low 590.85 | 567.20
Day's Volumes 342,586
52Wk High | Low 610.00 | 352.65
Open Price 567.20
Turnover 198,335,758.50
Deliverable Vol. 170,451
6 Mth. Avg. Vol. 502,077.57

Jun 19,2013 Open LTP Day's Range Volume
  567.20 571.45 590.85 - 567.20 342,586

No Data
Graph: Today |   1w |   1m |   3m |   6m |   1y |   3y Technical Charting  
IndiaInfoline
Make opportunities on the move…get daily stocks tips on your mobile.
Click here for details OR just SMS TIPS to 567675555

Key ratios

  Mar-12 Mar-11 Mar-10
P/E (x) 32.45 36.45 56.77
P/BV (x) 3.81 3.87 4.05
RONW (%) 12.7 11.3 8.6
ROCE (%) 11.7 11.9 9.1
EV/ EVBIDTA (x) 23.94 24.55 32.81
Dividend Yield (%) 0.3 0.3 0.3
APATM(%) 16.2 17.4 12.5
EPS 9.5 7.8 4.7

Shareholding Pattern

Particulars No. of
Shares(Mn) 		% Holdings
Total Promoter Holdings 130.84 48.3
Total Govt Holding (Promoter + Non Promoter) 0.00 0.0
Total Domestic Institutions (Banks/ FI + MF / UTI) 21.98 8.1
Total Foreign Holdings (FII+NRI holdings) 89.12 32.9
Total Non Promoter Corporate Holdings 3.79 1.4
Total Public & Others (Individuals + HUF + Clearing members) 25.13 9.3
Total 270.85 100
View detailed shareholding pattern next

Peer Comparison

Company Market Cap
(Rs. in Cr.) 		P/E (TTM)
(x) 		P/BV (TTM)
(x) 		EV/EBIDTA
(x) 		ROE
(%) 		ROCE
(%) 		D/E
(x)
Sun Pharma.Inds. 99,536.69 192.62 12.78 27.45 26.1 27.0 0.01
Dr Reddy's Labs 35,691.50 28.20 4.69 18.79 14.3 16.6 0.25
Cipla 30,498.16 20.24 3.44 14.11 15.9 19.8 0.03
Cadila Health. 16,246.12 34.82 5.64 18.45 28.4 24.2 0.40
Glenmark Pharma. 15,472.45 40.08 6.13 23.94 12.7 11.7 0.39
Ranbaxy Labs. 14,984.09 0.00 7.80 72.87 0.0 0.0 2.38
Wockhardt 11,962.85 32.47 14.62 12.82 237.0 30.3 2.09
Piramal Enterp. 9,614.49 0.00 0.91 23.66 0.8 2.1 0.07
Ipca Labs. 8,769.01 26.46 5.59 10.09 24.2 23.7 0.49
Torrent Pharma. 7,166.47 12.43 4.34 11.66 29.6 25.5 0.48
Biocon 5,512.00 19.22 2.50 12.20 12.6 13.6 0.08
Aurobindo Pharma 5,279.46 10.65 1.80 22.89 10.7 8.8 1.01
Strides Arcolab 5,002.13 34.10 3.65 46.94 7.3 8.9 0.56
Mylan Lab. 3,273.19 6.80 1.77 0.00 26.9 26.1 0.59
Alembic Pharma 2,739.85 17.41 5.96 5.60 39.5 27.7 1.07

Futures & Options Quote

 
Expiry Date
NA
Instrument: NA
Expiry Date: NA
Strike Price: NA
Open Price: NA
Average Price: NA
No. of Contracts Traded: NA
Open Interest: NA
Underlying: NA
Option Type: NA
Market Lot: NA
Previous Close: NA
Day’s High | Low: NA | NA
Turnover (Cr.): NA
Open Int. Change: NA | NA
View detailed F& O quotes >>

Key Information

Key Executives:

Glenn Saldanha , Chairman and MD & CEO  

Julio F Ribeiro , Director  

Natvarlal B Desai , Director  

Sridhar Gorthi , Director  

Company Head Office / Quarters:
B/2 Mahalaxmi Chambers,
22 Bhulabhai Desai Road,
Mumbai,
Maharashtra-400026
Phone : 91-22-40189999/879/56549999
Fax : 91-22-40189986/23512177/23519652
E-mail : complianceofficer@glenmarkpharma.com
Web : http://www.glenmarkpharma.com
Registrars:
Karvy Computershare Pvt Ltd
Plot No 17-24
Vittal Rao Nagar
Madhapur
Hyderabad-500081

Fund Holding

 

Calendar

Jun-2013
M T W T F S S
17 18 19 20 21 22 23
IPO
listNo IPO today
Economic Events
list ANZ Job Advertisements (MoM)
list EIA Natural Gas Storage Change
Results
list Havells India | Union Bank (I) | Dena Bank | Central Bank